Merck Serono, the biopharmaceutical division of Merck, has invited applications for the Merck Serono Innovation Cup 2014. This worldwide initiative is aimed at graduate students and postdocs of medicine, biotechnology, bioinformatics, biochemistry and pharmacy, who are interested in the discovery and development of new medicines. MBA graduates with a life science background and talented future scientists from all universities worldwide can apply. Applications can be submitted till March 15, 2014 online at innovationcup.merckserono.com. The one-week summer training camp will take place from July 13 to 18, 2014 in Darmstadt.
The Merck Serono Innovation Cup offers 30 selected participants the opportunity to familiarise themselves in a one-week summer training camp with the basics of pharmaceutical industry research and development. In teams, they develop ideas for innovations in oncology, immuno-oncology, autoimmune diseases, chemo and bioengineering, drug formulation as well as medical devices/electronic health and elaborate these ideas into concrete project plans with assistance from coaches. The participants learn first-hand what it means to discover and develop new drugs and what requirements must be met in order to successfully launch new drugs. At the end of the training camp, the teams present their project plans to a jury composed of Merck executives and external experts. The team that presents the most convincing plan will win the Innovation Cup, which involves prize money of € 10,000. The training camp will take place from July 13 to 18 in Darmstadt, Germany.
The Merck Serono Innovation Cup has been taking place annually since its launch in 2011. With this initiative, Merck Serono wants to promote the personal development of postgraduates who have the potential to become the top researchers or managers of tomorrow. At the same time, the programme serves as a forum for exchanging ideas on medical innovations. Seven of the ideas developed during the summer camps of recent years are currently being further processed by Merck researchers; several of the former camp participants are involved in this work.
EP News Bureau – Mumbai